Primary Care Optometry

Top Story

Glare, reduced contrast in patient with chorioretinal atrophy

Primary Care Optometry News, November 2017
Bonnie-Kim Hang, OD

A 74-year-old Caucasian man presented with a chief complaint of gradually impaired contrast and progressively increased glare that was worse in the left eye compared to the right eye, as well as bilateral reduced peripheral and central vision that persisted for several months.

The patient’s ocular history was significant for nuclear sclerotic cataracts in the left eye and a posterior chamber intraocular lens in the right eye that was implanted in 2008. The patient’s medical history was positive for hyperlipidemia, depression and diabetes.

From The Editor

Genetic testing for AMD: Not an ‘all-or-nothing’ proposition

Primary Care Optometry News, November 2017
Michael D. DePaolis, OD, FAAO
In many respects, we live in a world of absolutes. For instance, in the late 1800s, Dr. Henry Pickering Bowditch proclaimed the “all-or-none law” to describe…
PCON Reports

Genetic testing for AMD first step toward personalized medicine in eye care

Primary Care Optometry News, November 2017
Personalized medicine has become a trend in many facets of health care, from oncology to cardiology, and genetic testing for age-related macular degeneration signals its…
Blog

BLOG: Don't always expect new changes to make sense

November 13, 2017
The road to health care reform is not a straight line. There are twists and turns in the road, and even some dead ends and detours. With the amount of time and paperwork…
More Headlines »
CME COPE

Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 1

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to…
More »
Video
Meeting News

VIDEO: New device helps patients create natural tears

September 15, 2017
More »
Resource Centers
American Academy of Optometry

American Academy of Optometry

Video
Meeting News

VIDEO: Aesthetics tied to ocular surface health

September 14, 2017
More »
Advertisement
Advertisement